mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾

OAÈë¿Ú
±¨¸æµ¥ÅÌÎÊ
ÔÚÏß¿Í·þ
mg±ùÇòÍ»ÆÆ(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÐÂÎÅÖÐÐÄ
News Center
»ùÒòɸ²éÈÃÏÂÒ»´ú²»ÔÙ“Ò×Ëé”
Ðû²¼£º2024/04/17

ÓÐÕâÑùһȺÈË £¬´Ó³öÉúÆð¾ÍÎÞ·¨ÏñÕý³£º¢×ÓÒ»ÑùËÁÒâ±¼³ÛÍæË£ £¬²»¾­Òâ¼äµÄС¿ÄÅö¶¼¿ÉÄÜÈÃËûÃÇѪÁ÷²»Ö¹ £¬»»¿ÅÑÀ³ÝÒ²¿ÉÄÜΣ¼°ÉúÃü......ËûÃÇÊDz£Á§Ò»Ñùƽ³£¡°Ò×Ë顱µÄº¢×Ó £¬ÐèÒª¸ü¶àµÄÌåÌùºÍºÇ»¤ £¬ËûÃǾÍÊÇѪÓѲ¡»¼Õß¡£


ÿÄêµÄ4ÔÂ17ÈÕÊÇÌìÏÂѪÓѲ¡ÈÕ¡£ÈÃÎÒÃÇÒ»ÆðÏàʶѪÓѲ¡ £¬¹ØעѪÓѲ¡µÄ¿Æѧ·ÀÖΡ£



ʲôÊÇѪÓѲ¡£¿


ѪÓѲ¡ÊÇÒ»×éÒÅ´«ÐÔ³öѪÐÔ¼²²¡ £¬ÆäÌØÕ÷ÔÚÓÚ»¼ÕßÌåÄÚȱ·¦Ä³Ð©Òªº¦µÄÄýѪÒò×Ó £¬µ¼ÖÂѪҺÎÞ·¨Õý³£Äý¹Ì £¬´Ó¶øÒý·¢Ò»ÏµÁгöѪ֢״¡£


ƾ֤Ëùȱ·¦µÄÄýѪÒò×ÓÖÖÀà £¬ÑªÓѲ¡Ö÷Òª·ÖΪÒÔÏÂÁ½ÖÖÀàÐÍ£º

  • ѪÓѲ¡A£¨¾­µä·¶ÑªÓѲ¡£©£ºÕâÊÇ×î³£¼ûµÄÀàÐÍ £¬Õ¼ËùÓÐѪÓѲ¡²¡ÀýµÄÔ¼80%-85%¡£ËüÊÇÓÉÄýѪÒò×Ó VIII£¨Òò×Ó°Ë£©µÄȱ·¦»ò¹¦Ð§ÕÏ°­ÒýÆðµÄ¡£


  • ѪÓѲ¡B£¨ÒÒÐÍѪÓѲ¡£©£ºÕâÀàѪÓѲ¡Õ¼Ê£ÓಡÀýµÄÔ¼15%-20% £¬ÓÉÄýѪÒò×Ó IX£¨Òò×Ӿţ©µÄȱ·¦»ò¹¦Ð§ÕÏ°­ÒýÆðµÄ¡£


ѪÓѲ¡»¼Õß×î´óµÄÌصã¾ÍÊÇ´ÓС¾Í±£´æ³öѪÇãÏò £¬ÔÚÊÜÉË»ò½ÓÊÜÊÖÊõºó £¬ÇáÕßÌ«¹ýÓÙѪ £¬ÖØÕßѪÁ÷²»Ö¹£»±ðµÄ £¬ÑªÓѲ¡»¼Õß³£ÓпڱdzöѪºÍ賦µÀ³öѪµÄÖ¢×´ £¬»¹¿ÉÄÜÓÉÓÚÖظ´µÄÊàŦ³öѪ¶øÌÛÍ´ÄÑÈÌÉõÖÁÊàŦËðÉË¡¢»ûÐζøµ¼Ö²м²¡£



ѪÓѲ¡ÎÞ·¨¸ùÖÎ £¬ÐèÖÕÉúÕÕ»¤


Òź¶µÄÊÇ £¬ÁÙ´²ÉÏÖÁ½ñÉÐÎÞ³¹µ×ÖÎÓúѪÓѲ¡µÄÒªÁì £¬»¼Õß±£´æÖÕÉíÕÕ»¤µÄÐèÇó¡£È«Çòҽѧ½çÒ»Á¬ÖÂÁ¦ÓÚ¸ÄÉÆѪÓѲ¡µÄÖÎÁÆÊÖ¶ÎÓëÌáÉý»¼ÕßµÄÉúÑÄÖÊÁ¿ £¬µ«Ïֽ׶εĽ¹µãÕ½ÂÔÈÔ¼¯ÖÐÔÚ¶àѧ¿ÆЭ×÷µÄ×ÛºÏÕÕ»¤ÉÏ¡£

΢ÐÅͼƬ_20240417132050(1).jpg

ѪÓѲ¡»¼ÕßµÄÖÎÁƺÍÕÕ»¤ÓÐÒÔÏÂÒªº¦Òªµã£º

Ìæ»»Òò×ÓÖÎÁÆ

ÕâÊÇѪÓѲ¡ÏÖÔÚµÄÖ÷ÒªÖÎÁÆÒªÁì £¬°üÀ¨Êä×¢ÏìÓ¦µÄÄýѪÒò×ÓÀ´Ôö²¹»¼ÕßµÄÄýѪ¹¦Ð§ £¬ÒÔïÔÌ­»ò×èÖ¹³öѪÊÂÎñµÄ±¬·¢¡£

³öѪÊÂÎñ¹ÜÀí

µ±³öѪÊÂÎñ±¬·¢Ê± £¬ÊµÊ±½ÓÄɲ½·¥ÒÔֹѪºÍ¼õÇáÖ¢×´ÖÁ¹ØÖ÷Òª £¬°üÀ¨Ê¹Óñù·ó¡¢Õ¥È¡¡¢Ìá¸ß»¼Ö«¡¢Êä×¢ÄýѪÒò×ÓµÈÒªÁì¡£

ÉúÑÄ·½·¨¹ÜÀí

¾ÙÐÐÊʶȵ͹¥»÷Ô˶¯ £¬¼á³ÖƽºâÒûʳ £¬×èÖ¹¸ßΣº¦»î¶¯ºÍʹÓÿÉÄÜ×ÌÈÅÄýѪµÄÒ©Îï¡£

°´ÆÚ¼à²âÓëµ÷½âÖÎÁÆ

°´ÆÚ¼ì²âÄýѪ¹¦Ð§¡¢ÆÀ¹ÀÊàŦ¿µ½¡¡¢É¸²é²¢·¢Ö¢ £¬Æ¾Ö¤²¡Çéµ÷½âÌæ»»Òò×ÓÖÎÁƼƻ®¡£

ÒÅ´«×Éѯ

»¼Õß¼°Æä¼ÒÍ¥Ó¦½ÓÊÜÒÅ´«×Éѯ £¬Ã÷È·²¡Òò¡¢ÒÅ´«·½·¨ £¬»ñÈ¡ÉúÓýΣº¦¹ÜÀí½¨Òé¡£



30%ÒÔÉϵÄѪÓѲ¡»¼Õß²¢Ã»ÓмÒ×åÊ·


ËäÈ» £¬ÑªÓѲ¡ÊÇÒ»ÖÖÒÅ´«ÐÔ¼²²¡ £¬µ«²¢²»ÁÏζ×ÅÕý³£¿µ½¡µÄØøÙ³¾Í²»»áÉú³ö»¼ÓÐѪÓѲ¡µÄº¢×Ó¡£ÊÂʵÉÏ £¬Í³¼ÆÊý¾ÝÕ¹ÏÖ £¬Áè¼Ý30%µÄѪÓѲ¡»¼Õß²¢ÎÞÒÑÖªµÄ¼Ò×岡ʷ¡£ÕâÊÇΪʲôÄØ£¿Ö÷ÒªÓÐÈýÖÖ¿ÉÄܵÄÔµ¹ÊÔ­ÓÉ£º


ÒþÐÔÒÅ´«ÌØÕ÷£ºÑªÓѲ¡×ñÕÕXȾɫÌåÁ¬ËøÒþÐÔÒÅ´«Ä£Ê½¡£Å®ÐÔЯ´øÕßͨ³£½öÓÐÒ»¸öÖ²¡»ùÒò £¬×ÔÉí²»·¢²¡ £¬µ«ÔÚÉúÓýÀú³ÌÖÐÓпÉÄܽ«¸Ã»ùÒòת´ï¸ø×ÓÅ®¡£Òò´Ë £¬¼Ò×åÖпÉÄܱ£´æδ±»Ê¶±ðµÄЯ´øÕß £¬Ö±ÖÁÆä×ÓÅ®·ºÆðÖ¢×´²ÅÏÔ¶³öÒÅ´«Á´¡£


¼Ò×åÊ·¼Í¼¾ÖÏÞ£ºÓÐʱ £¬¼Ò×岡ʷ¼Í¼¿ÉÄܲ»È«»ò½û¾øÈ·¡£ÊÜÏÞÓÚÊìϤȱ·¦»ò¹ýÍùÒ½ÁÆˮƽÊÖÏÞÐÔ £¬¼Ò×åÖпÉÄÜÒÑÓл¼²¡Õ߶øδ±»Ã÷È·Õï¶Ï £¬´Ó¶øÔÚÍâòÉÏ·ºÆðÎÞ¼Ò×åÊ·µÄÕ÷Ïó¡£


з¢Í»±ä£ºÖ»¹ÜÏà¶Ô½ÏÉÙ¼û £¬µ«ÑªÓѲ¡²¡ÀýÒ²¿ÉÄÜÓÉз¢Í»±äÒýÆð¡£¼´ÔÚâïÊÑË«·½µÄÉúֳϸ°ûÐγɻòÊܾ«ÂÑÐγɡ¢ÅßÌ¥·¢ÓýÔçÆÚ±¬·¢µÄ»ùÒòÍ»±ä £¬×ª´ïµ½ÁËÏÂÒ»´ú¡£ÕâÖÖÇéÐÎÔÚÒÅ´«Æ×ϵÉÏÌåÏÖΪ¡°Í»È»·ºÆ𡱠£¬Ã»ÓÐÏÈÇ°µÄ¼Ò×廼²¡¼Í¼¡£


Òò´Ë £¬×ÝÈ»¼Ò×åÖÐδÔø·ºÆð¹ýѪÓѲ¡²¡Àý £¬¸öÌåÈÔÓпÉÄÜî¾»¼¸Ã²¡¡£¹ØÓÚÈκβ»Ã÷Ôµ¹ÊÔ­ÓɵÄÒ»Á¬ÐÔ»òÖظ´·ºÆðµÄ³öѪ֢״ £¬ÈçƤ·ôÓÙѪ¡¢ÆµÈÔÁ÷±ÇѪ¡¢¿ÚÇ»³öѪ £¬ÒÔ¼°ÊàŦÖ×ÕÍÌÛÍ´µÈ £¬¾ùÓ¦Ìá¸ßСÐÄ £¬ÊµÊ±¾ÍÒ½¡£



»ùÒòɸ²éÖúÁ¦ÑªÓѲ¡·À¿ØÌáÉýÉú³Ý¿µ½¡ËØÖÊ


»ùÒòɸ²éÔÚѪÓѲ¡µÄ·À¿ØÖоßÓв»¿ÉÌæ»»µÄְλ¡£Ëü²»µ«ÄÜÓÐÓÃÔ¤·ÀѪÓѲ¡»¼¶ùµÄ³öÉú £¬ÖúÁ¦ÔçÆÚÕï¶ÏÓë¸ÉÔ¤ £¬»¹ÄÜÕ¹ÏÖÒþÐÔЯ´øÕßµÄÒÅ´«Î£º¦ £¬Ö¸µ¼ÖÖÖÖÈËȺ¾ÙÐкÏÀíµÄÉúÓý¹ÜÀí £¬¶ÔÌáÉýÉú³Ý¿µ½¡ËØÖÊ¡¢¼õÇáÉç»áÒ½ÁƼ縺Æðµ½ÁËÒªº¦×÷Óá£


¹ØÓÚѪÓѲ¡»¼ÕßÀ´Ëµ £¬ÈôÊÇÉúÓýÁËͬÑù»¼ÓÐѪÓѲ¡µÄº¢×Ó £¬½«¶Ô¼ÒÍ¥´øÀ´¸ü¼«Öصļ縺¡£Òò´Ë £¬ÑªÓѲ¡»¼ÕߵļÒÍ¥ÐèÒª¾ÙÐÐרҵµÄÒÅ´«×ÉѯºÍÐëÒªµÄ»ùÒò¼ì²â £¬ÔÚרҵҽÉúµÄÖ¸µ¼ÏÂÑ¡Ôñ²úÇ°Õï¶Ï»òµÚÈý´ú¸¨ÖúÉúÖ³µÈÊֶΠ£¬×èÖ¹ÏÂÒ»´ú»¼¶ùµÄ³öÉú¡£


±ðµÄ £¬Ã»ÓÐÁÙ´²ÌåÏֵĿµ½¡Å®ÐÔÒ²¿ÉÄÜÊÇѪÓѲ¡Ö²¡»ùÒòµÄЯ´øÕß £¬¶øËýÃǵÄ×ÓŮҲ±£´æ×ÅѪÓѲ¡µÄ»¼²¡Î£º¦¡£Òò´Ë £¬¼´¼´ÊÇ¿µ½¡Õý³£µÄØøÙ³ £¬ÔÚ±¸ÔÐÆÚ»òÕßÔÐÔçÆÚ¾ÙÐÐѪÓѲ¡Ïà¹ØµÄ»ùÒòɸ²éÒ²ÊǺÜÊÇÓÐÒâÒåµÄ £¬Õâ¿ÉÒÔ×ÊÖúËûÃÇÏàʶ×ÔÉíµÄÖ²¡»ùÒòЯ´øÇéÐÎ £¬ÖªÏþ×ÓÅ®µÄ»¼²¡Î£º¦²¢¾ÙÐпÆѧµÄÉúÓý¹ÜÀí £¬´Ó¶øµÖ´ïÓÅÉúÓÅÓýµÄÄ¿µÄ £¬ÓÐÓýµµÍѪÓѲ¡µÄ·¢²¡ÂÊ¡£



²Î¿¼ÎÄÏ×


[1] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð­×÷×é. (2017). ѪÓѲ¡Õï¶ÏÓëÖÎÁÆÖйúר¼Ò¹²Ê¶(2017Äê°æ). ÖлªÑªÒºÑ§ÔÓÖ¾, 38(5), 364-370.

[2] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð­×÷×é. (2020). ѪÓѲ¡ÖÎÁÆÖйúÖ¸ÄÏ(2020Äê°æ).

[3] Ljung, Rolf,Auerswald, Guenter,Benson, Gary, et al. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients[J].European Journal of Haematology.2019,102(2).

[4] Ê¯ºìËÉ, À¸Ö, ÒüÑÞ, ÍõÓ§, & Íõ´¿. (2016). ¼×ÐÍѪÓѲ¡»ùÒòЯ´øÕß¼ì³ö¼°²úÇ°Õï¶ÏÑо¿. ÖлªÊÊÓÃÕï¶ÏÓëÖÎÁÆÔÓÖ¾, 30(4), 3.




ÍøÕ¾µØͼ